ONC Launches Funding Opportunity to Accelerate AI and Improve Healthcare Data Interoperability
Funding aims to accelerate AI adoption in clinical settings, improve health data monitoring tools, and standardize lab codes
Read More
AbbVie Drug Expected to Rival Bristol Myers’s New Schizophrenia Med Flunks Phase 2 Test
AbbVie schizophrenia drug candidate emraclidine failed to beat a placebo in two Phase 2 clinical trials. The drug, once projected to compete with Bristol Myers Squibb’s Cobenfy, is from AbbVie’s $8.7 billion acquisition of Cerevel Therapeutics. The post AbbVie Drug Expected to Rival Bristol Myers’s New Schizophrenia Med Flunks Phase 2 Test appeared first on…
Many ACA Customers Are Paying Higher Premiums. Most Blame Trump and Republicans, Poll Finds.
Most people who get their health coverage through the Affordable Care Act say they face sharply higher costs, with many worried they will have to pare back other expenses to cover them, according to a poll released Thursday. Some are uncertain whether they will be able to continue paying their premiums all year. Still, 69%…
MedCity Pivot Podcast: Putting a Human Touch on Healthcare Navigation and Coordination
Heather Cox, President of Insights & Empowerment at Zelis, talked about the company’s care coordination tools with MedCity News Reporter Katie Adams. The post MedCity Pivot Podcast: Putting a Human Touch on Healthcare Navigation and Coordination appeared first on MedCity News.
State of Claims 2024: Insights from survey findings
Despite increased access to claims management technology, claims denials are still on the rise in 2024. Contributing factors include growing healthcare costs, stricter payer reimbursement policies, and claims processing errors. Providers are seeing an uptick in nonpayment, plus an added burden on administrative staff, disrupted patient care, and hits to the bottom line. Experian Health…
What are concerns with IRA drug price negotiations for part B drugs?
There were lots of very interesting sessions at ISPOR 2025 in Montreal. One of my favorites that I was able to attend was titled “Medicare Price Negotiation of Part B Drugs: Implications for Provider Reimbursement and Commercial Spillover“. The session was moderated by Sean Sullivan of University of Washington, with Kristi Martin from the Centers…
Servier Boosts Presence in Rare Cancers With $2.5B Acquisition of Day One Biopharma
Day One Biopharmaceuticals is Servier’s biggest acquisition yet, topping the $2.4 billion it paid to buy Shire’s cancer business in 2018. Day One markets Ojemda, approved for treating pediatric low-grade glioma, the most common type of brain cancer in children. The post Servier Boosts Presence in Rare Cancers With $2.5B Acquisition of Day One Biopharma…
Noom Launches Oral Medication Offering for Weight Loss
Noom will begin offering oral medications for weight loss, starting with Metformin. This can support those who have a needle version or have a lower body mass index than indicated for GLP-1s. The post Noom Launches Oral Medication Offering for Weight Loss appeared first on MedCity News.
American Heart Association Backs Auxira Health to Alleviate Cardiologist Burnout
The American Heart Association’s venture arm invested in Auxira Health, a startup that embeds virtual clinical teams into cardiology practices to reduce physician burnout and expand patient access. By handling routine tasks like follow-up visits and medication refills, Auxira gives cardiologists the opportunity to focus on complex care without adding full-time staff. The post American…
Atria Health Launches National Partnership Model to Keep Cardiology Practices Independent
Atria Health launched its partnership model for cardiology practices nationwide this week. Instead of buying and then subsequently owning practices, Atria provides capital, expertise and technology to help cardiologists build independent, physician-led practices. The post Atria Health Launches National Partnership Model to Keep Cardiology Practices Independent appeared first on MedCity News.